BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30031845)

  • 1. Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.
    Thornblade LW; Mulligan MS; Odem-Davis K; Hwang B; Waworuntu RL; Wolff EM; Kessler L; Wood DE; Farjah F
    Ann Thorac Surg; 2018 Nov; 106(5):1460-1467. PubMed ID: 30031845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spread Through Air Spaces Is a Prognostic Factor in Sublobar Resection of Non-Small Cell Lung Cancer.
    Shiono S; Endo M; Suzuki K; Yarimizu K; Hayasaka K; Yanagawa N
    Ann Thorac Surg; 2018 Aug; 106(2):354-360. PubMed ID: 29625101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer.
    Brown LM; Louie BE; Jackson N; Farivar AS; Aye RW; Vallières E
    Ann Thorac Surg; 2016 Oct; 102(4):1110-8. PubMed ID: 27350237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters.
    Seder CW; Arndt AT; Jordano L; Basu S; Fhied CL; Sayidine S; Chmielewski GW; Gallo K; Liptay MJ; Borgia JA
    Ann Thorac Surg; 2017 Nov; 104(5):1637-1643. PubMed ID: 28964418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.
    Brandt WS; Yan W; Leeman JE; Tan KS; Park BJ; Adusumilli PS; Bott MJ; Molena D; Isbell J; Chaft J; Rimner A; Jones DR
    Ann Thorac Surg; 2018 Sep; 106(3):848-855. PubMed ID: 29807005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
    Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
    Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.
    David E; Thall PF; Kalhor N; Hofstetter WL; Rice DC; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA; Wei C; Mehran RJ
    Ann Thorac Surg; 2013 Jun; 95(6):1872-7; discussion 1877. PubMed ID: 23643547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Persistent Problem of Local/Regional Failure After Surgical Intervention for Early-Stage Lung Cancer.
    Judy GD; Kaidar-Person O; Deal A; Wang Y; Migliardi A; Long J; Haithcock B; Marks LB
    Ann Thorac Surg; 2018 Aug; 106(2):382-389. PubMed ID: 29723532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Ann Thorac Surg; 2014 May; 97(5):1701-7. PubMed ID: 24679941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar Resection in the Treatment of Peripheral Typical Carcinoid Tumors of the Lung.
    Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Filosso PL; Guerrera F; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
    Ann Thorac Surg; 2019 Sep; 108(3):859-865. PubMed ID: 31059684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.
    Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M
    Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.